Short answer
Healthpeak Properties (DOC) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.10 (Exhibit EX-99.10), Item EX-99.30 (Exhibit EX-99.30), Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Item EX-99.1). Q2 2026 results covered three and six months ended June 30, 2026.
Healthpeak Properties 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results covered three and six months ended June 30, 2026
- Healthpeak issued the earnings release on August 4, 2026
- Detailed financial results and non-GAAP reconciliations available in Exhibits 99.1, 99.3 and 99.4
Item 7.01 · Regulation FD Disclosure
- Supplemental report covers Healthpeak’s three and six months ended June 30, 2026
- Exhibit 99.2 contains financial results and related investor information
- Report availability on Healthpeak’s Investor Relations website supports investor review of quarterly performance
Item EX-99.1 · Item EX-99.1
- Q2 revenue rose to $771.6M, while FFO as Adjusted held at $0.46 per share, signaling stable underlying earnings
- 2026 FFO guidance increased to $1.73-$1.77 per share, with same-store cash NOI guidance raised to 0%-1.5%
- Brookfield recapitalization generated $1.025B from a 49% outpatient medical stake, supporting deleveraging and capital recycling
- Net debt to Adjusted EBITDAre improved to 4.7x; proceeds funded repayment of $650M senior notes and approximately $375M commercial paper
- Janus Living delivered 45% revenue growth and 34% Adjusted EBITDAre growth, but senior housing expansion increases Healthpeak’s operating exposure
Item EX-99.10 · Exhibit EX-99.10
- Q2 net income $0.08 per share and adjusted FFO $0.46, with FFO flat year over year
- 2026 guidance raised: adjusted FFO $1.73-$1.77 per share, midpoint up $0.02
- Brookfield recapitalization generated approximately $1.025 billion, while total year-to-date proceeds reached $1.75 billion
- Debt reduction strengthened liquidity: $650 million senior notes and approximately $375 million commercial paper repaid after quarter-end
- Janus Living growth accelerated, revenue up 45% to $216 million and adjusted EBITDAre up 34% to $79 million
Item EX-99.30 · Exhibit EX-99.30
- Exhibit defines Healthpeak’s non-GAAP metrics for the quarter and six months ended June 30, 2026
- FFO as Adjusted, Adjusted NOI, and Adjusted EBITDAre are key REIT performance measures alongside GAAP results
- Leverage metrics include Net Debt to Adjusted EBITDAre, Financial Leverage, and Secured Debt Ratio
- Same-store Cash NOI is designed to isolate underlying portfolio performance from acquisitions, dispositions, and redevelopment activity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Healthpeak Properties 8-K filings
Get the next DOC 8-K as it lands
Follow DOC for push alerts, or ask the research agent what this filing means.